Health
New study charts the complexity of SARS-CoV-2 neutralization – EurekAlert
In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains…
Washington, DC – February 24, 2021 – In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains antibodies against the coronavirus. But not every type of antibody can neutralize the virus and render it noninfectious. New research published this week in mSphere, an open-access journal of the American Society for Microbiology, explores variation in virus neutralization capabilities, which can vary…
-
General15 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
General20 hours agoCritically endangered orchid thrives as NSW Mid North Coast cemetery provides habitat refuge
-
Noosa News18 hours agoSanta drops in for carols
-
Business20 hours agoThe best Australian stock you’ve never heard of